175 related articles for article (PubMed ID: 36045266)
21. Treatment outcomes and risk factors of patients with intracranial germ cell tumour with choriocarcinoma element or β-HCG level higher than 500 IU/L.
Feng J; Zhang J; Chen L; Li C; Liu W; Chen H; Qiu X; Li B
J Neurooncol; 2024 Jan; 166(2):331-339. PubMed ID: 38236548
[TBL] [Abstract][Full Text] [Related]
22. Secreting germ cell tumors of the central nervous system (CNS). First results of the cooperative German/Italian pilot study (CNS sGCT).
Calaminus G; Andreussi L; Garré ML; Kortmann RD; Schober R; Göbel U
Klin Padiatr; 1997; 209(4):222-7. PubMed ID: 9293454
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors and therapeutic problems of primary intracranial choriocarcinoma/germ-cell tumors with high levels of HCG.
Shinoda J; Sakai N; Yano H; Hattori T; Ohkuma A; Sakaguchi H
J Neurooncol; 2004 Jan; 66(1-2):225-40. PubMed ID: 15015791
[TBL] [Abstract][Full Text] [Related]
24. Intracranial Germ Cell Tumors.
Yeoh TDYY; Nga V; Kimpo M; Lo SS; Vellayappan B
Semin Neurol; 2023 Dec; 43(6):897-908. PubMed ID: 37963583
[TBL] [Abstract][Full Text] [Related]
25. Multimodality treatment for Central Nervous System Germ Cell Tumors: Disease spectrum and management strategies - A tertiary care center experience from India.
Kumar N; Madan R; Dracham CB; Khosla D; Das N; Dey T; Elangovan A; Tripathi M; Gupta K; Ahuja CK; Kapoor R
Clin Neurol Neurosurg; 2021 Mar; 202():106481. PubMed ID: 33508649
[TBL] [Abstract][Full Text] [Related]
26. Improved prognosis of intracranial non-germinoma germ cell tumors with multimodality therapy.
Robertson PL; DaRosso RC; Allen JC
J Neurooncol; 1997 Mar; 32(1):71-80. PubMed ID: 9049865
[TBL] [Abstract][Full Text] [Related]
27. Treatment and survival of primary intracranial germ cell tumors: a population-based study using SEER database.
Denyer S; Bhimani AD; Patil SN; Mudreac A; Behbahani M; Mehta AI
J Cancer Res Clin Oncol; 2020 Mar; 146(3):671-685. PubMed ID: 31745701
[TBL] [Abstract][Full Text] [Related]
28. Challenges in the Management of Childhood Intracranial Germ Cell Tumors in Middle-Income Countries: A 20-Year Retrospective Review From a Single Tertiary Center in Malaysia.
Rajagopal R; Leong SH; Jawin V; Foo JC; Ahmad Bahuri NF; Mun KS; Azman RR; Loh J; Yap TY; Ariffin H; Moreira DC; Gottardo NG; Bouffet E; Ganesan D
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e913-e923. PubMed ID: 33633029
[TBL] [Abstract][Full Text] [Related]
29. Histologically confirmed intracranial germ cell tumors; an analysis of 62 patients in a single institute.
Lee D; Suh YL
Virchows Arch; 2010 Sep; 457(3):347-57. PubMed ID: 20652714
[TBL] [Abstract][Full Text] [Related]
30. A pragmatic diagnostic approach to primary intracranial germ cell tumors and their treatment outcomes.
Venkatasai J; Balakrishnan R; Rajkrishna B; Sebastain P; John RR; Vanjare HA; Prabhu K; Nair B; Mathew LG; Backianathan S
CNS Oncol; 2021 Nov; 10(4):CNS79. PubMed ID: 34806399
[TBL] [Abstract][Full Text] [Related]
31. EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults.
Frappaz D; Dhall G; Murray MJ; Goldman S; Faure Conter C; Allen J; Kortmann RD; Haas-Kogen D; Morana G; Finlay J; Nicholson JC; Bartels U; Souweidane M; Schönberger S; Vasiljevic A; Robertson P; Albanese A; Alapetite C; Czech T; Lau CC; Wen P; Schiff D; Shaw D; Calaminus G; Bouffet E
Neuro Oncol; 2022 Apr; 24(4):516-527. PubMed ID: 34724065
[TBL] [Abstract][Full Text] [Related]
32. Optimal radiotherapy target volumes in intracranial nongerminomatous germ cell tumors: Long-term institutional experience with chemotherapy, surgery, and dose- and field-adapted radiotherapy.
Breen WG; Blanchard MJ; Rao AN; Daniels DJ; Buckner JC; Laack NNI
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28695992
[TBL] [Abstract][Full Text] [Related]
33. Optimal treatment strategy for intracranial germ cell tumors: a single institution analysis.
Kanamori M; Kumabe T; Saito R; Yamashita Y; Sonoda Y; Ariga H; Takai Y; Tominaga T
J Neurosurg Pediatr; 2009 Dec; 4(6):506-14. PubMed ID: 19951035
[TBL] [Abstract][Full Text] [Related]
34. Intracranial germ cells tumour: a single institution experience in Argentina.
Baroni LV; Oller A; Freytes CS; Sampor CV; Pinto N; Fernandez NP; Rugilo C; Lubieniecki F; Zubizarreta P; Alderete D
J Neurooncol; 2021 Apr; 152(2):363-372. PubMed ID: 33660119
[TBL] [Abstract][Full Text] [Related]
35. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
[TBL] [Abstract][Full Text] [Related]
36. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
37. Correlation of endoscopic biopsy with tumor marker status in primary intracranial germ cell tumors.
Luther N; Edgar MA; Dunkel IJ; Souweidane MM
J Neurooncol; 2006 Aug; 79(1):45-50. PubMed ID: 16598424
[TBL] [Abstract][Full Text] [Related]
38. Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors.
Modak S; Gardner S; Dunkel IJ; Balmaceda C; Rosenblum MK; Miller DC; Halpern S; Finlay JL
J Clin Oncol; 2004 May; 22(10):1934-43. PubMed ID: 15143087
[TBL] [Abstract][Full Text] [Related]
39. Cytokeratin 7, inhibin, and p63 in testicular germ cell tumor: superior markers of choriocarcinoma compared to β-human chorionic gonadotropin.
Wegman SJ; Parwani AV; Zynger DL
Hum Pathol; 2019 Feb; 84():254-261. PubMed ID: 30359635
[TBL] [Abstract][Full Text] [Related]
40. Morphologic features of human chorionic gonadotropin- or alpha-fetoprotein-producing germ cell tumors of the central nervous system: histological heterogeneity and surgical meaning.
Sugiyama K; Arita K; Tominaga A; Hanaya R; Taniguchi E; Okamura T; Itoh Y; Yamasaki F; Kurisu K
Brain Tumor Pathol; 2001; 18(2):115-22. PubMed ID: 11908867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]